Patents Assigned to Genesis Laboratories, Inc.
  • Publication number: 20170280722
    Abstract: The invention relates to a new rapid release oral formulation of fipronil or imidacloprid for the effective control of blood-sucking insect populations. Embodiments of the invention relate to their use by incorporation into a feed-through formulation that can be administered orally to host animals such as birds, goats, dogs, and cattle for the rapid effective control of blood sucking insects. The formulation is fast acting and the residue of the chemicals present in the feces serves as a larvacide, effectively controlling newly hatched larvae.
    Type: Application
    Filed: June 23, 2017
    Publication date: October 5, 2017
    Applicant: GENESIS LABORATORIES, INC.
    Inventor: Richard POCHE
  • Patent number: 9550897
    Abstract: A method and composition of a photo chromic dye suitable to be applied directly to human skin, and which dye is configured to indicate exposure to UV rays. The composition is configured to change color upon exposure to UVA, UVB and/or UVC rays. The composition can be used with other compositions, such as sunscreen, and be applied to human skin prior to application of the sunscreen, or, formulated with the sunscreen such that when the active ingredients of the sunscreen diminish, the photo chromic dye will change color to generate a visual indicator of this condition.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: January 24, 2017
    Assignee: GENESIS LABORATORIES, INC.
    Inventors: Clifton Sanders, Courtland Imel
  • Patent number: 9545374
    Abstract: A method and composition of a photo chromic dye suitable to be applied directly to human skin, and which dye is configured to indicate exposure to UV rays. The composition is configured to change color upon exposure to UVA, UVB and/or UVC rays. The composition can be used with other compositions, such as sunscreen, and be applied to human skin prior to application of the sunscreen, or, formulated with the sunscreen such that when the active ingredients of the sunscreen diminish, the photo chromic dye will change color to generate a visual indicator of this condition.
    Type: Grant
    Filed: May 3, 2016
    Date of Patent: January 17, 2017
    Assignee: GENESIS LABORATORIES, INC.
    Inventors: Clifton Sanders, Courtland Imel
  • Publication number: 20160089316
    Abstract: A composition for protecting from ultraviolet radiation is disclosed. The composition comprises a filter and an effectiveness indicator responsive to the reduction of effectiveness protection.
    Type: Application
    Filed: June 17, 2015
    Publication date: March 31, 2016
    Applicant: GENESIS LABORATORIES INC.
    Inventor: Clifton Sanders
  • Publication number: 20150230469
    Abstract: The invention relates to a new rapid release oral formulation of fipronil or imidacloprid for the effective control of blood-sucking insect populations. Embodiments of the invention relate to their use by incorporation into a feed-through formulation that can be administered orally to host animals such as birds, goats, dogs, and cattle for the rapid effective control of blood sucking insects. The formulation is fast acting and the residue of the chemicals present in the feces serves as a larvacide, effectively controlling newly hatched larvae.
    Type: Application
    Filed: April 30, 2015
    Publication date: August 20, 2015
    Applicant: GENESIS LABORATORIES, INC.
    Inventor: Richard POCHE
  • Publication number: 20140057987
    Abstract: Compositions are provided that comprise a disinfectant, a pH indicator dye, and an alkaline substance. The pH indicator dye expresses a color when initially sprayed, but loses or changes color once sprayed. The compositions may be used to disinfect surfaces, and the pH indicator dye indicates what surface has been disinfected and ensures that a sufficient period of time has passed to disinfect the surface. Dispensing systems that are not fully air tight are provided for containing and dispensing the composition.
    Type: Application
    Filed: December 5, 2011
    Publication date: February 27, 2014
    Applicant: GENESIS LABORATORIES, INC.
    Inventors: James R. Vinson, Phillip G. Pitts
  • Publication number: 20130035303
    Abstract: The invention relates to a new rapid release oral formulation of fipronil or imidacloprid for the effective control of blood-sucking insect populations. Embodiments of the invention relate to their use by incorporation into a feed-through formulation that can be administered orally to host animals such as birds, goats, dogs, and cattle for the rapid effective control of blood sucking insects. The formulation is fast acting and the residue of the chemicals present in the feces serves as a larvacide, effectively controlling newly hatched larvae.
    Type: Application
    Filed: April 21, 2011
    Publication date: February 7, 2013
    Applicant: Genesis Laboratories, Inc.
    Inventor: Richard Poche
  • Patent number: 6264969
    Abstract: A method is described for controlling or exterminating moles through the use of a bait composition in the form of a gel, paste, or grease. The composition includes an attractant and an active ingredient capable of killing vertebrate pests. The composition is injected into a mole tunnel through a small diameter nozzle, tube or needle to avoid digging open the tunnel or causing it to collapse.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: July 24, 2001
    Assignee: Genesis Laboratories, Inc.
    Inventor: Richard M. Poche
  • Patent number: 5932437
    Abstract: A method is described for controlling the spread of Lyme Disease spirochete from rodents which have been infected. The method involves orally administering to the rodents a composition which includes an antibiotic (e.g., tetracycline) which is capable of killing the spirochete. Bait compositions are described which include an antibiotic. The bait compositions may be solid or liquid.
    Type: Grant
    Filed: April 13, 1998
    Date of Patent: August 3, 1999
    Assignee: Genesis Laboratories, Inc.
    Inventor: Richard M. Poche